457 related articles for article (PubMed ID: 31520800)
21. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
Unlu O; Erkan D; Barbhaiya M; Andrade D; Nascimento I; Rosa R; Banzato A; Pengo V; Ugarte A; Gerosa M; Ji L; Efthymiou M; Branch DW; de Jesus GR; Tincani A; Belmont HM; Fortin PR; Petri M; Rodriguez E; Pons-Estel GJ; Knight JS; Atsumi T; Willis R; Zuily S; Tektonidou MG;
Arthritis Care Res (Hoboken); 2019 Jan; 71(1):134-141. PubMed ID: 29669399
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of aPS/PT antibodies in neuropsychiatric lupus and cardiovascular complications of systemic lupus erythematosus.
Ramirez GA; Canti V; Del Rosso S; Erra R; Moiola L; Magnoni M; Bozzolo EP; Manfredi AA; Rovere-Querini P
Autoimmunity; 2020 Feb; 53(1):21-27. PubMed ID: 31782311
[No Abstract] [Full Text] [Related]
23. Antiphospholipid Antibodies in Lupus Nephritis.
Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmström V; Svenungsson E; Gunnarsson I
PLoS One; 2016; 11(6):e0158076. PubMed ID: 27336701
[TBL] [Abstract][Full Text] [Related]
24. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
[TBL] [Abstract][Full Text] [Related]
25. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
26. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
Chen J; Sun S; Yan Q; Bao C; Fu Q
Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
[TBL] [Abstract][Full Text] [Related]
27. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
28. Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus.
Gustafsson JT; Gunnarsson I; Källberg H; Pettersson S; Zickert A; Vikerfors A; Möller S; Rönnelid J; Elvin K; Svenungsson E
Ann Rheum Dis; 2015 Aug; 74(8):1537-43. PubMed ID: 24692586
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
30. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.
Taraborelli M; Lazzaroni MG; Martinazzi N; Fredi M; Cavazzana I; Franceschini F; Tincani A
Reumatismo; 2016 Dec; 68(3):137-143. PubMed ID: 27981815
[TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.
Love PE; Santoro SA
Ann Intern Med; 1990 May; 112(9):682-98. PubMed ID: 2110431
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus.
Amoroso A; Mitterhofer AP; Del Porto F; Garzia P; Ferri GM; Galluzzo S; Vadacca M; Caccavo D; Afeltra A
Hum Immunol; 2003 Feb; 64(2):265-73. PubMed ID: 12559629
[TBL] [Abstract][Full Text] [Related]
33. Study of antiphospholipid antibodies by enzyme immunoassay and chemiluminescent methods in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data).
Cheldieva FA; Reshetnyak TM; Cherkasova MV; Lila AM
Klin Lab Diagn; 2021 Sep; 66(9):546-551. PubMed ID: 34543533
[TBL] [Abstract][Full Text] [Related]
34. Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature.
Franco AMM; Medina FMC; Balbi GGM; Levy RA; Signorelli F
Lupus; 2020 Oct; 29(12):1528-1543. PubMed ID: 32814509
[TBL] [Abstract][Full Text] [Related]
35. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
36. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus.
Demir S; Li J; Magder LS; Petri M
Rheumatology (Oxford); 2021 Aug; 60(8):3770-3777. PubMed ID: 33331921
[TBL] [Abstract][Full Text] [Related]
37. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
[TBL] [Abstract][Full Text] [Related]
38. MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus.
Goldstein R; Moulds JM; Smith CD; Sengar DP
J Rheumatol; 1996 Jul; 23(7):1173-9. PubMed ID: 8823688
[TBL] [Abstract][Full Text] [Related]
39. Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
Huang J; Zhu Q; Wang B; Wang H; Xie Z; Zhu X; Zhao T; Yang Z
Expert Rev Clin Immunol; 2024 Jul; 20(7):793-801. PubMed ID: 38445835
[TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?
Ghirardello A; Doria A; Ruffatti A; Rigoli AM; Vesco P; Calligaro A; Gambari PF
Ann Rheum Dis; 1994 Feb; 53(2):140-2. PubMed ID: 8129460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
